Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Myeloid 1Classical hematology 1

Conditions

Colorectal Neoplasms 8Venous Thromboembolism 4Polycythemia Vera 3Prostatic Neoplasms 2Neoplasms 2Myeloproliferative Disorders 2Fallopian Tube Neoplasms 2Colorectal Neoplasms, Hereditary Nonpolyposis 2Breast Neoplasms 2Thrombocythemia, Essential 1Testicular Neoplasms 1Smoking Cessation 1Sarcoma 1Primary Myelofibrosis 1Ovarian Neoplasms 1Ovarian Cancer Prevention 1Neuroma, Acoustic 1Neurofibromatosis 2 1Neoplasms, Germ Cell and Embryonal 1Multiple Myeloma 1Motor Activity 1Lung Neoplasms 1Liver Cirrhosis 1Leukemia, Hairy Cell 1Inflammation 1Hemorrhage 1Hematoma 1Fibrosis 1Endometrial Neoplasms 1Colorectal Neoplasia 1

Interventions

Tranexamic Acid 2carbetocin 1Sutures 1Surgicel 1Solutions 1Sodium Chloride 1Saline Solution 1Neuromuscular Blockade 1N(4)-oleylcytosine arabinoside 1Methylergonovine 1Injections, Intravenous 1FloSeal Matrix 1Ergonovine 1Endoscopic Mucosal Resection 1Bevacizumab 1Aspirin 1Ascorbic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Hemorrhage × Aspirin × 1 year × Clear all
NCT05198960 2026-03-20

AVAJAK

University Hospital, Brest

Phase 3 Recruiting
1,308 enrolled
Classical hematologyMyeloid

Hemorrhage, Polycythemia Vera, Thrombocythemia, Essential, Venous Thromboembolism, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡